How We're Keeping You Safe | What Patients & Families Need to Know
Member, Division of Experimental Hematology & Cancer Biology
Associate Professor, UC Department of Pathology and Laboratory Medicine
Experimental Hematology and Cancer Biology, Cancer and Blood Diseases
Gang Huang, PhD, Katherine A. Auger, MD, MSc ...8/11/2020
BS: Peking University, College of Science, Beijing, P.R. China, 1991.
MS: Inner Mongolia University, Graduate School of Science, Huhhort, P.R. China, 1994.
PhD: Kyoto University, Graduate School of Medicine, Kyoto, Japan, 2001.
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients.
Chen, L; Long, X; Xu, Q; Tan, J; Wang, G; Cao, Y; Wei, J; Luo, H; Zhu, H; Huang, L; et al.
Cellular and Molecular Immunology.
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centre.
Huang, H; Xu, C; Gao, J; Li, B; Qin, T; Xu, Z; Ren, S; Zhang, Y; Jiao, M; Qu, S; et al.
Blood Cancer Journal.
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial.
Cao, Y; Wei, J; Zou, L; Jiang, T; Wang, G; Chen, L; Meng, F; Huang, L; Wang, N; Zhou, X; et al.
Journal of Allergy and Clinical Immunology.
Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia.
Huang, H; Qin, T; Xu, Z; Shi, Z; Li, B; Pan, L; Hu, N; Qu, S; Huang, G; Gale, RP; et al.
British Journal of Haematology.
The Role of RUNX1 in NF1-Related Tumors and Blood Disorders.
Na, Y; Huang, G; Wu, J.
Molecules and Cells.
The Clinical, Molecular, and Mechanistic Basis of RUNX1 Mutations Identified in Hematological Malignancies.
Yokota, A; Huo, L; Lan, F; Wu, J; Huang, G.
Molecules and Cells.
DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells.
Bera, R; Chiu, M; Huang, Y; Huang, G; Lee, Y; Shih, L.
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway.
Chen, S; Wang, Q; Yu, H; Capitano, ML; Vemula, S; Nabinger, SC; Gao, R; Yao, C; Kobayashi, M; Geng, Z; et al.
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints.
Dong, Y; Zhao, X; Feng, X; Zhou, Y; Yan, X; Zhang, Y; Bu, J; Zhan, D; Hayashi, Y; Zhang, Y; et al.
Prognostic mutations in persons with isolated neutropenia myelodysplastic syndrome.
Shi, Z; Qin, T; Xu, Z; Li, B; Huang, H; Zhang, H; Fang, L; Pan, L; Hu, N; Qu, S; et al.
Leukemia and Lymphoma.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462
© 1999-2020 Cincinnati Children's Hospital Medical Center. All rights reserved.